PRA Health Sciences Inc (PRAH)-医療機器分野:企業M&A・提携分析

◆英語タイトル:PRA Health Sciences Inc (PRAH) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011479
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:42
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
PRA Health Sciences Inc (PRA) is a contract research organization(CRO) which provides clinical development services. The company offers services such as phase I-IV study management, and embedded and functional outsourcing services. It offers solutions in bioanalytical laboratories, biometrics, clinical pharmacology, strategic solutions, post-marketing research, clinical diagnostics, and safety and risk management. PRA spans its expertise in the therapeutic areas of biosimilars, oncology, hematology, respiratory, rare diseases, neurology, infectious diseases, cardio-metabolic and immunology. It caters to pharmaceutical and biotechnology industries. The company has presence in the US, Hong Kong, Russia, India, France, Italy, China, Japan, South Africa, Israel and Colombia among others. PRA is headquartered in Raleigh, North Carolina, the US.

PRA Health Sciences Inc (PRAH) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
PRA Health Sciences Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
PRA Health Sciences Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
PRA Health Sciences Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
PRA Health Sciences Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
PRA Health Sciences Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
PRA Health Sciences Inc, Medical Equipment, Deal Details 10
Private Equity 10
Warburg Pincus Completes Acquisition Of ReSearch Pharma Services 10
Partnerships 12
Care Innovations Enters into Partnership with PRA Health Sciences 12
Equity Offering 13
PRA Health Sciences Prices Public Offering of Shares 13
PRA Health Sciences Raises USD416.3 Million in Public Offering of Shares 15
Acquisition 17
PRA Health Sciences Acquires Symphony Health Solutions 17
PRA Health Sciences Inc – Key Competitors 19
PRA Health Sciences Inc – Key Employees 20
PRA Health Sciences Inc – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Joint Venture 23
Recent Developments 24
Strategy And Business Planning 24
May 04, 2017: PRA Health Sciences Announces The Center for Pediatric Clinical Development 24
Financial Announcements 25
Oct 25, 2017: PRA Health Sciences Reports Third Quarter 2017 Results and Updates Full Year 2017 Guidance 25
Aug 07, 2017: PRA Health Sciences Reports Second Quarter 2017 Results and Updates Full Year 2017 Guidance 27
Apr 25, 2017: PRA Health Sciences Reports First Quarter 2017 Results 29
Feb 22, 2017: PRA Health Sciences Reports Fourth Quarter and Full Year 2016 Results and Provides Q1 and Full Year 2017 Guidance 31
Nov 02, 2016: PRA Health Sciences Reports Third Quarter 2016 Results and Updates 2016 Guidance 33
Jul 28, 2016: PRA Health Sciences Reports Second Quarter 2016 Results 35
Apr 27, 2016: PRA Health Sciences Reports First Quarter 2016 Results and Updates 2016 Guidance 36
Feb 24, 2016: PRA Health Sciences Reports Fourth Quarter and Full Year 2015 Results and Provides 2016 Guidance 37
Corporate Communications 39
Aug 14, 2017: PRA Health Sciences Announces Appointment of New Director 39
May 22, 2017: PRA Health Sciences Named International Clinical Research Company of the Year 40
May 02, 2017: PRA Health Sciences Named Clinical Research Company of the Year 41
Appendix 42
Methodology 42
About GlobalData 42
Contact Us 42
Disclaimer 42

List of Tables
PRA Health Sciences Inc, Medical Equipment, Key Facts, 2016 2
PRA Health Sciences Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
PRA Health Sciences Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
PRA Health Sciences Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
PRA Health Sciences Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
PRA Health Sciences Inc, Deals By Market, 2011 to YTD 2017 8
PRA Health Sciences Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Warburg Pincus Completes Acquisition Of ReSearch Pharma Services 10
Care Innovations Enters into Partnership with PRA Health Sciences 12
PRA Health Sciences Prices Public Offering of Shares 13
PRA Health Sciences Raises USD416.3 Million in Public Offering of Shares 15
PRA Health Sciences Acquires Symphony Health Solutions 17
PRA Health Sciences Inc, Key Competitors 19
PRA Health Sciences Inc, Key Employees 20
PRA Health Sciences Inc, Other Locations 21
PRA Health Sciences Inc, Subsidiaries 22
PRA Health Sciences Inc, Joint Venture 23

★海外企業調査レポート[PRA Health Sciences Inc (PRAH)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Vossloh AG:企業の戦略・SWOT・財務情報
    Vossloh AG - Strategy, SWOT and Corporate Finance Report Summary Vossloh AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Eickhoff Corporation:企業の戦略・SWOT・財務分析
    Eickhoff Corporation - Strategy, SWOT and Corporate Finance Report Summary Eickhoff Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Bioceros BV-製薬・医療分野:企業M&A・提携分析
    Summary Bioceros BV (Bioceros) is a biopharmaceutical company which provides services related to preclinical development of monoclonal antibodies. The company offers GMP-ready protein producing cell lines. The company provides services which include monoclonal antibody generation, cell line and proc …
  • Navitas Limited (NVT):企業の財務・戦略的SWOT分析
    Navitas Limited (NVT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Trianni Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Trianni Inc (Trianni) is a developer of fully human monoclonal antibodies that provides its propriety discovery platform. The company provides Trianni Mouse platform that holds engineered versions of three antibody-encoding genetic loci, namely, Heavy, Kappa, Lambda, and others. It enables t …
  • Oneok Inc (OKE):石油・ガス:M&Aディール及び事業提携情報
    Summary Oneok Inc (ONEOK) is an oil and gas company that processes, gathers, storages and transports natural gas. The company's products include natural gas and natural gas liquids. It offers services such as natural gas, natural gas pipelines, and natural gas liquids gathering, processing, marketin …
  • Veolia Environnement SA (VIE)-エネルギー分野:企業M&A・提携分析
    Summary Veolia Environnement SA (Veolia) is an environmental management services company that designs and offers water, waste and energy management solutions. Its service offerings include wastewater and sanitation services, drinking water treatment and distribution and waste management and energy s …
  • Versantis AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Versantis AG (Versantis) is a pharmaceutical company that develops new generation of medicines and diagnostics for treating patients with liver diseases. The company’s pipeline product includes VS-01, a liposomal-based peritoneal dialysis fluid that acts as a clearance enhancer for a large s …
  • Rural Bank Limited
    Rural Bank Limited - Strategy, SWOT and Corporate Finance Report Summary Rural Bank Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Osiris Therapeutics Inc (OSIR):企業の財務・戦略的SWOT分析
    Osiris Therapeutics Inc (OSIR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • IHI Corporation:企業のM&A・事業提携・投資動向
    IHI Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's IHI Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Intershop Communications AG (ISH2):企業の財務・戦略的SWOT分析
    Summary Intershop Communications AG (Intershop), formerly NetConsult GmbH, is an information technology company that develops and offers integrated e-commerce solutions. The company provides services such as omni-channel management, experience management, product information management, marketing an …
  • KineMed Inc:医療機器:M&Aディール及び事業提携情報
    Summary KineMed Inc (KineMed) is a biotechnology company that develops and commercializes proprietary biomarker platform technology. The company applies its proprietary biomarker platform technology to drug development, prescription, and non-prescription medical diagnostics and the pairing of drugs …
  • Golden Queen Mining Co. Ltd.:企業の戦略・SWOT・財務情報
    Golden Queen Mining Co. Ltd. - Strategy, SWOT and Corporate Finance Report Summary Golden Queen Mining Co. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Global Clean Energy Holdings Inc:企業の戦略的SWOT分析
    Global Clean Energy Holdings Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Leica Microsystems GmbH:企業のM&A・事業提携・投資動向
    Leica Microsystems GmbH - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Leica Microsystems GmbH Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Bayer AG (BAYN):製薬・医療:M&Aディール及び事業提携情報
    Summary Bayer AG (Bayer) carries out the research, development, production and commercialization of products for human and animal health care, and agriculture. It provides medicines for cardiovascular diseases, women’s health, cancer, hematology, ophthalmology and other indications. The company's pr …
  • Dollarama Inc:戦略・SWOT・企業財務分析
    Dollarama Inc - Strategy, SWOT and Corporate Finance Report Summary Dollarama Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • M3 Midstream LLC:石油・ガス:M&Aディール及び事業提携情報
    Summary M3 Midstream LLC (Momentum) is an independent oil and gas company that offers midstream oilfield services. The company provides services such as gas processing and treating, wellhead gathering, dehydration, fractionation, compression, and storage services for natural gas and natural gas liqu …
  • FluoroPharma Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary FluoroPharma Medical Inc (FluoroPharma) is a molecular imaging company that develops and commercialize proprietary medical diagnostic imaging products. The company develops breakthrough positron emission tomography imaging agents for the assessment and detection of acute and chronic forms of …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆